Lucid Diagnostics (LUCD) Short Interest Ratio & Short Volume → Exposed: 10 CENT Crypto to Explode May 20th? (From True Market Insiders) (Ad) Free LUCD Stock Alerts $0.90 +0.02 (+2.26%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Lucid Diagnostics Short Interest DataCurrent Short Volume456,800 sharesPrevious Short Volume361,400 sharesChange Vs. Previous Month+26.40%Dollar Volume Sold Short$411,576.80Short Interest Ratio / Days to Cover2.1Last Record DateApril 30, 2024Outstanding Shares52,110,000 sharesFloat Size14,750,000 sharesShort Percent of Float3.10%Today's Trading Volume85,652 sharesAverage Trading Volume269,847 sharesToday's Volume Vs. Average32% Short Selling Lucid Diagnostics ? Sign up to receive the latest short interest report for Lucid Diagnostics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatLUCD Short Interest Over TimeLUCD Days to Cover Over TimeLUCD Percentage of Float Shorted Over Time Ad Crypto 101 MediaThe Overlooked Retirement Asset You Probably Don’t Own4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. Lucid Diagnostics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024456,800 shares $411,576.80 +26.4%3.1%2.1 $0.90 4/15/2024361,400 shares $292,734.00 -18.1%2.5%2.2 $0.81 3/31/2024441,000 shares $357,165.90 +91.1%3.8%3.1 $0.81 3/15/2024230,800 shares $256,188.00 +13.9%2.3%2.2 $1.11 2/29/2024202,600 shares $249,198.00 +9.6%2.0%2.8 $1.23 2/15/2024184,900 shares $253,313.00 +46.1%1.8%3 $1.37 Get the Latest News and Ratings for LUCD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lucid Diagnostics and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024126,600 shares $178,506.00 +16.4%1.8%2.8 $1.41 1/15/2024108,800 shares $165,376.00 -8.5%1.0%2.7 $1.52 12/31/2023118,900 shares $167,649.00 -25.4%1.1%3.1 $1.41 12/15/2023159,300 shares $208,683.00 +32.8%1.5%3.5 $1.31 11/30/2023120,000 shares $177,600.00 +0.8%1.2%2.8 $1.48 11/15/2023119,100 shares $158,403.00 +9.6%1.2%2.7 $1.33 10/31/2023108,700 shares $140,223.00 +12.4%1.1%2.4 $1.29 10/15/202396,700 shares $117,974.00 -2.8%1.0%2.2 $1.22 9/30/202399,500 shares $116,415.00 +0.4%1.0%2.1 $1.17 9/15/202399,100 shares $150,632.00 +14.6%1.0%2.3 $1.52 8/31/202386,500 shares $133,210.00 -15.4%0.9%1.7 $1.54 8/15/2023102,300 shares $152,427.00 -12.9%1.0%1.9 $1.49 7/31/2023117,400 shares $164,360.00 -1.1%1.2%2.2 $1.40 7/15/2023118,700 shares $157,871.00 -20.8%1.2%2.2 $1.33 6/30/2023149,900 shares $208,361.00 +5.6%1.5%2.6 $1.39 6/15/2023141,900 shares $227,040.00 +21.8%1.4%2.2 $1.60 5/31/2023116,500 shares $185,235.00 +12.0%1.2%1.6 $1.59 5/15/2023104,000 shares $154,960.00 -35.4%1.1%1.2 $1.49 4/30/2023160,900 shares $236,523.00 +32.2%1.4%1.7 $1.47 4/15/2023121,700 shares $165,512.00 -35.4%1.1%1.2 $1.36 3/31/2023188,300 shares $263,620.00 +41.1%2.3%1.7 $1.40 3/15/2023133,500 shares $236,295.00 -19.0%1.7%1.3 $1.77 2/28/2023164,800 shares $224,128.00 +13.1%2.2%1.8 $1.36 2/15/2023145,700 shares $190,867.00 -30.0%2.0%1.8 $1.31 1/31/2023208,100 shares $272,611.00 -4.3%2.8%2.9 $1.31 1/15/2023217,400 shares $282,620.00 -0.4%3.0%3.1 $1.30 12/30/2022218,200 shares $296,752.00 +32.6%3.0%3.8 $1.36 12/15/2022164,500 shares $268,135.00 -33.2%2.2%2.7 $1.63 11/30/2022246,100 shares $457,746.00 +17.0%3.6%3.9 $1.86 11/15/2022210,300 shares $420,600.00 +33.9%2.9%3.2 $2.00 10/31/2022157,100 shares $301,632.00 -4.4%2.2%2 $1.92 10/15/2022164,300 shares $280,953.00 -23.2%2.4%1.8 $1.71 9/30/2022213,800 shares $327,114.00 +20.7%3.1%2.3 $1.53 9/15/2022177,200 shares $363,260.00 -8.9%2.5%1.8 $2.05[URGENT] DO NOT Touch These AI Stocks! (Ad)Artificial intelligence stocks are carrying the market. One of them, Nvidia, recently became the seventh company ever to hit a $1 trillion market cap. But is this AI rally over?Click here for our #1 AI Stock for 2024 and Beyond LUCD Short Interest - Frequently Asked Questions What is Lucid Diagnostics' current short interest? Short interest is the volume of Lucid Diagnostics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 456,800 shares of LUCD short. 3.10% of Lucid Diagnostics' shares are currently sold short. Learn More on Lucid Diagnostics' current short interest. What is a good short interest ratio for Lucid Diagnostics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LUCD shares currently have a short interest ratio of 2.0. Learn More on Lucid Diagnostics's short interest ratio. What is a good short interest percentage for Lucid Diagnostics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.10% of Lucid Diagnostics' floating shares are currently sold short. Is Lucid Diagnostics' short interest increasing or decreasing? Lucid Diagnostics saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 456,800 shares, an increase of 26.4% from the previous total of 361,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Lucid Diagnostics' float size? Lucid Diagnostics currently has issued a total of 52,110,000 shares. Some of Lucid Diagnostics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lucid Diagnostics currently has a public float of 14,750,000 shares. How does Lucid Diagnostics' short interest compare to its competitors? 3.10% of Lucid Diagnostics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Lucid Diagnostics: LENSAR, Inc. (0.74%), Cytosorbents Co. (2.85%), Daxor Co. (0.47%), Apyx Medical Co. (1.90%), Carmell Co. (0.19%), IceCure Medical Ltd (1.39%), DarioHealth Corp. (4.51%), Beyond Air, Inc. (11.21%), Modular Medical, Inc. (0.70%), Co-Diagnostics, Inc. (1.45%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Lucid Diagnostics stock? Short selling LUCD is an investing strategy that aims to generate trading profit from Lucid Diagnostics as its price is falling. LUCD shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lucid Diagnostics? A short squeeze for Lucid Diagnostics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LUCD, which in turn drives the price of the stock up even further. How often is Lucid Diagnostics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LUCD, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: LNSR Short Squeeze CTSO Short Squeeze DXR Short Squeeze APYX Short Squeeze CTCX Short Squeeze ICCM Short Squeeze DRIO Short Squeeze XAIR Short Squeeze MODD Short Squeeze CODX Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LUCD) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingBuy this small stock before coming AI Tidal WaveChaikin AnalyticsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersUrgent Nvidia WarningAltimetry41 banks launch ‘crypto dollar’Stansberry ResearchMost important medical advance in 100 yearsThe Oxford ClubForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press